Dr Oludare Odumosu has experience in pharmaceutical product research and development, operations and strategic alliance management. He has led global business development activities to support existing product commercialisation and new product formulation validation, regulatory approvals, product launch, global supply and operations.
Dr Odumosu has been the chief operating officer of Ilera Healthcare LLC since July 2017. Ilera was acquired by Zelda Therapeutics and in December 2019, Mr Odumosu joined the board of the newly-merged entity Zelira Therapeutics. He became the global managing director of Zelira in February 2021 following the company's strategic consolidation to have a leadership team based in the US.